224 related articles for article (PubMed ID: 14515339)
1. Effects of fenfluramine and antidepressants on protein kinase C activity in rat cortical synaptoneurosomes.
Giambalvo CT; Price LH
Synapse; 2003 Dec; 50(3):212-22. PubMed ID: 14515339
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of amphetamine transport vs. dopamine reverse transport on particulate PKC activity in striatal synaptoneurosomes.
Giambalvo CT
Synapse; 2003 Aug; 49(2):125-33. PubMed ID: 12740868
[TBL] [Abstract][Full Text] [Related]
3. Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA) occurs through the stimulation of serotonin receptors and transporter.
Kramer HK; Poblete JC; Azmitia EC
Neuropsychopharmacology; 1997 Sep; 17(3):117-29. PubMed ID: 9272479
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the translocation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA/ecstasy) in synaptosomes: evidence for a presynaptic localization involving the serotonin transporter (SERT).
Kramer HK; Poblete JC; Azmitia EC
Neuropsychopharmacology; 1998 Oct; 19(4):265-77. PubMed ID: 9718590
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a role of transporter-mediated currents in the depletion of brain serotonin induced by serotonin transporter substrates.
Baumann MH; Bulling S; Benaderet TS; Saha K; Ayestas MA; Partilla JS; Ali SF; Stockner T; Rothman RB; Sandtner W; Sitte HH
Neuropsychopharmacology; 2014 May; 39(6):1355-65. PubMed ID: 24287719
[TBL] [Abstract][Full Text] [Related]
6. Characterization of D-fenfluramine-induced hypothermia: evidence for multiple sites of action.
Cryan JF; Harkin A; Naughton M; Kelly JP; Leonard BE
Eur J Pharmacol; 2000 Mar; 390(3):275-85. PubMed ID: 10708734
[TBL] [Abstract][Full Text] [Related]
7. 1-(m-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain.
Baumann MH; Ayestas MA; Dersch CM; Rothman RB
Neuropsychopharmacology; 2001 May; 24(5):492-501. PubMed ID: 11282249
[TBL] [Abstract][Full Text] [Related]
8. The serotonergic antidepressant nefazodone inhibits the serotonin transporter: in vivo and ex vivo studies.
Owens MJ; Ieni JR; Knight DL; Winders K; Nemeroff CB
Life Sci; 1995; 57(24):PL373-80. PubMed ID: 7475971
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms underlying the effects of amphetamine on particulate PKC activity.
Giambalvo CT
Synapse; 2004 Feb; 51(2):128-39. PubMed ID: 14618680
[TBL] [Abstract][Full Text] [Related]
10. Carrier-mediated serotonin release induced by d-fenfluramine: studies with human neuroblastoma cells transfected with a rat serotonin transporter.
Cinquanta M; Ratovitski T; Crespi D; Gobbi M; Mennini T; Simantov R
Neuropharmacology; 1997 Jun; 36(6):803-9. PubMed ID: 9225308
[TBL] [Abstract][Full Text] [Related]
11. Serotonin (5-HT) transporter ligands affect plasma 5-HT in rats.
Rothman RB; Zolkowska D; Baumann MH
Ann N Y Acad Sci; 2008 Oct; 1139():268-84. PubMed ID: 18991872
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro interaction of flunarizine with D-fenfluramine serotonergic effects.
Mennini T; Gobbi M; Crespi D; Cinquanta M; Frittoli E; Giorcelli P; Anelli M; Caccia S
Pharmacol Biochem Behav; 1996 Jan; 53(1):155-61. PubMed ID: 8848445
[TBL] [Abstract][Full Text] [Related]
13. Amphetamine action at the cocaine- and antidepressant-sensitive serotonin transporter is modulated by αCaMKII.
Steinkellner T; Montgomery TR; Hofmaier T; Kudlacek O; Yang JW; Rickhag M; Jung G; Lubec G; Gether U; Freissmuth M; Sitte HH
J Neurosci; 2015 May; 35(21):8258-71. PubMed ID: 26019340
[TBL] [Abstract][Full Text] [Related]
14. p-Chlorophenylalanine and fluoxetine inhibit D-fenfluramine-induced Fos expression in the paraventricular nucleus, cingulate cortex and frontal cortex but not in other forebrain and brainstem regions.
Javed A; Van De Kar LD; Gray TS
Brain Res; 1997 Nov; 774(1-2):94-105. PubMed ID: 9452197
[TBL] [Abstract][Full Text] [Related]
15. In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: sibutramine is a reuptake inhibitor.
Gundlah C; Martin KF; Heal DJ; Auerbach SB
J Pharmacol Exp Ther; 1997 Nov; 283(2):581-91. PubMed ID: 9353373
[TBL] [Abstract][Full Text] [Related]
16. Release studies with rat brain cortical synaptosomes indicate that tramadol is a 5-hydroxytryptamine uptake blocker and not a 5-hydroxytryptamine releaser.
Gobbi M; Mennini T
Eur J Pharmacol; 1999 Apr; 370(1):23-6. PubMed ID: 10323276
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
Tordera RM; Monge A; Del Río J; Lasheras B
Eur J Pharmacol; 2002 May; 442(1-2):63-71. PubMed ID: 12020683
[TBL] [Abstract][Full Text] [Related]
18. Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.
Crespi D; Mennini T; Gobbi M
Br J Pharmacol; 1997 Aug; 121(8):1735-43. PubMed ID: 9283711
[TBL] [Abstract][Full Text] [Related]
19. Cocaine and selective monoamine uptake blockers (sertraline, nisoxetine, and GBR 12935) prevent the d-fenfluramine-induced head-twitch response in mice.
Darmani NA
Pharmacol Biochem Behav; 1998 May; 60(1):83-90. PubMed ID: 9610928
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of rat brain 5-HT uptake carriers after treatment with high doses of D-fenfluramine.
Gobbi M; Mancini L; Presti ML; Mennini T
Brain Res; 1996 Aug; 730(1-2):165-72. PubMed ID: 8883900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
